| P2093 | author name string | Fei Yu | |
| | Likun Hou | |
| | Chunyan Wu | |
| | Da Fu | |
| | Pei Luo | |
| | Yushui Ma | |
| | Zhongwei Lv | |
| | Chengyou Jia | |
| P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| | The potential role of ubiquitin c-terminal hydrolases in oncogenesis | Q28277081 |
| | MicroRNA-125-5p targeted CXCL13: a potential biomarker associated with immune thrombocytopenia | Q33423573 |
| | Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells | Q33991823 |
| | Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer | Q34067225 |
| | Microarray-based analysis: identification of hypoxia-regulated microRNAs in retinoblastoma cells | Q34168469 |
| | A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. | Q34240949 |
| | Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF. | Q34328740 |
| | miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion | Q34477328 |
| | MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers | Q35113043 |
| | The challenges and the promise of molecular targeted therapy in malignant gliomas | Q35214534 |
| | Increased Expression of TGFβR2 Is Associated with the Clinical Outcome of Non-Small Cell Lung Cancer Patients Treated with Chemotherapy | Q35739691 |
| | MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway. | Q35918962 |
| | Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma | Q36413501 |
| | MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma | Q37295098 |
| | Quantitative assessment of the influence of TP63 gene polymorphisms and lung cancer risk: evidence based on 93,751 subjects | Q37510681 |
| | Global correlation analysis for micro-RNA and mRNA expression profiles in human cell lines | Q38513760 |
| | MicroRNA-498 is downregulated in non-small cell lung cancer and correlates with tumor progression | Q38839257 |
| | EGCG enhances the efficacy of cisplatin by downregulating hsa-miR-98-5p in NSCLC A549 cells | Q39006577 |
| | MicroRNA hsa-miR-125a-3p activates p53 and induces apoptosis in lung cancer cells | Q39094729 |
| | Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A. | Q39108050 |
| | MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells | Q39176326 |
| | Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance | Q39398613 |
| | Identification of altered MicroRNA expression patterns in synovial sarcoma | Q39611039 |
| | Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia | Q39852549 |
| | Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma | Q39964030 |
| | MicroRNA miR-125a-3p modulates molecular pathway of motility and migration in prostate cancer cells | Q42028379 |
| | Prognostic implications for high expression of MiR-25 in lung adenocarcinomas of female non-smokers | Q44028247 |
| | Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer | Q44952449 |
| | MicroRNA classifiers for predicting prognosis of squamous cell lung cancer | Q46661715 |
| | MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2. | Q48145576 |
| | miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1. | Q53376880 |
| | MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. | Q54424273 |
| | Germline mutation of microRNA-125a is associated with breast cancer | Q57828433 |
| | Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer | Q87319145 |
| P433 | issue | 4 | |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 4441-4448 | |
| P577 | publication date | 2017-08-24 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | MicroRNA-125a-3p downregulation correlates with tumorigenesis and poor prognosis in patients with non-small cell lung cancer | |
| P478 | volume | 14 | |